Bcr-Abl inhibitor CT-721, Purity ≥98%

Synonym: 1388710-60-8; Bcr-Abl inhibitor; CT721; CT -721

Product Size

1 mg; 5 mg; 10 mg; 25 mg

Price

Datasheet

Datasheet

MSDS

MSDS

Properties

Description

CT-721 specifically inhibits the activity of the Bcr-Abl tyrosine kinase.

Molecular Weight

525.04

Molecular Formula

C₃₀H₂₉ClN₆O

Form

Lyophilized powder

Purity

≥98%

Identity

Confirmed by NMR/HPLC/MS.

Applications

CT-721 focuses on interfering with the Bcr-Abl signaling pathway, relevant for treating Philadelphia chromosome-positive leukemias.